Orsola Vitagliano

Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse

Chiara Rusconi, Chan Y. Cheah, Toby A. Eyre et al. · Blood · 2022 · 46 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patients

Salvatore Palmieri, Stefano Rocco, Orsola Vitagliano et al. · Annals of Hematology · 2020 · 16 citations

Medicine, Hematology, Oncology +13

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group

Gian Matteo Rigolin, Francesco Cavazzini, Alfonso Piciocchi et al. · Hematological Oncology · 2021 · 11 citations · Full text

Medicine, Oncology, Pharmacotherapy +13